Intended for healthcare professionals

CCBYNC Open access

Rapid response to:

Research

Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1225 (Published 31 March 2015) Cite this as: BMJ 2015;350:h1225

Rapid Response:

Re: Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials

Misguided and irresponsible research in my opinion. It is siloing diseases. As if someone with osteoarthritis has just the one condition? There are usually a few chronic conditions floating around in the ONE body. So in my view Panadol Osteo is an overarching first line pain relief and it works. Your study is flawed in my view for this reason. Now it has been taken off the PBS the cost has doubled (there is no price stabilization in sight ..in fact quite the opposite....now the strike off the PBS genie is out of the bottle and costs will continue to escalate because there are no controls in place) for those who can least afford it. They are left with no other option than to go to their second line of pain relief OxyContin and Endone. Crazy world of eroding Medicare and the PBS and cost shifting to the sick and vulnerable by this government. The study did not take into account that there may be multiple conditions and just the one body and that overall Panadol may be working at a multi disease level.

Competing interests: No competing interests

09 March 2016
Gabrielle Rose
Medical Anthropologist
None
Pro Box 3401, Newmarket, 4503